Abbott amends by-laws to update shareholder nomination procedures and special meeting rules

On December 9, 2022, Abbott’s Board of Directors amended and restated Abbott’s by-laws (the “Amended and Restated By-Laws”), effective immediately. The Amended and Restated By-laws, among other things: · Update and clarify the procedural mechanics and information requirements for shareholder nominations of directors and shareholder proposals (other than proposals to be included in Abbott’s proxy materials pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at shareholder meetings, including to address matters relating to Rule 14a-19 under the Exchange Act; · Update certain procedural mechanics for special meetings of shareholders; · Clarify the powers of the Board and the Chair of a shareholder meeting to regulate conduct at such meeting; and · Make various other updates, including ministerial and conforming changes, as well as changes in furtherance of gender neutrality.